Mike Ward, Senior Director of eSource Capabilities at Lilly, has dedicated his 28-year career to advancing clinical trial data collection within Lilly and across the pharmaceutical industry. He leads Lilly’s efforts to transform clinical trial operations through digital enablement, with a particular focus on electronic source (eSource) adoption and electronic medical record to electronic data capture (EMR-to-EDC) integration.
Mike leads the implementation of site platforms, such as CRIO eSource, to streamline source data capture and reduce site burden. He also oversees eCOA platform validation and account management operations across more than 100 active studies and five vendor platforms, ensuring regulatory compliance and operational continuity. He partners closely with IgniteData, Genospace, and Veeva to advance seamless EMR-to-EDC interoperability, enabling real-time data flow and improving data quality across studies. Together, these programs accelerate trial timelines and strengthen data integrity from site to submission.
In addition to his operational leadership, Mike has been an active driver of industry standards through leadership roles with the CDISC Clinical Data Acquisition Standards Harmonization (CDASH) working group, Health Level Seven International (HL7), and TransCelerate. He serves as a sponsor advisor for i~HD’s eSource Scale-up Task Force, whose mission is to “collectively drive and scale eSource implementation, revolutionizing the setup and execution of clinical trials worldwide.”